v3.25.2
NOTE 9 – STOCKHOLDERS’ DEFICIT (Details Narrative) - USD ($)
 12 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Accumulated Other Comprehensive Income (Loss) [Line Items]    
Common Stock, Shares Authorized 675,000,000 675,000,000
Common Stock, Par or Stated Value Per Share $ 0.001 $ 0.001
Stock Issued During Period, Shares, Issued for Services 295,000 720,000
Share-Based Payment Arrangement, Noncash Expense $ 132,662 $ 211,698
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price $ 0.50  
Stock Issued During Period, Shares, New Issues 2,550,000 393,250
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period 5,675,355  
Shares Issuance With Warrants 1 [Member]    
Accumulated Other Comprehensive Income (Loss) [Line Items]    
Common Stock, Par or Stated Value Per Share $ 0.001 $ 0.001
Stock Issued During Period, Shares, New Issues 2,550,000 343,250
Stock Issued During Period, Value, New Issues $ 2,550,000 $ 343,250
Temporary Equity, Contract Terms Warrants were issued for each share purchased, for a total of 2,550,000 warrants. The warrants are exercisable at one dollar ($1.00) per share and expire in February 2027. Five warrants were issued for each share purchased, for a total of 1,716,250 warrants. The warrants are exercisable at twenty ($0.20) cents and expire from April 2025 through September 2025.
Shares Issuance With Warrants 2 [Member]    
Accumulated Other Comprehensive Income (Loss) [Line Items]    
Common Stock, Par or Stated Value Per Share   $ 0.001
Stock Issued During Period, Shares, New Issues   50,000
Stock Issued During Period, Value, New Issues   $ 50,000
Temporary Equity, Contract Terms   One warrant was issued for each share purchased for a total of 50,000 warrants. The warrants are exercisable at one dollar ($1.00) and expire January 19, 2026.
Warrants To Board Members And Consultants [Member]    
Accumulated Other Comprehensive Income (Loss) [Line Items]    
Share-Based Payment Arrangement, Noncash Expense $ 55,562 $ 82,098
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized 3,067,105 842,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value $ 55,562 $ 85,132
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price $ 0.33  
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term 5 years  
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum 4.65%  
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 5.48%  
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate 0.00%  
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate 80.00%  
Warrants To Board Members And Consultants [Member] | Minimum [Member]    
Accumulated Other Comprehensive Income (Loss) [Line Items]    
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Date Jul. 01, 2029  
Warrants To Board Members And Consultants [Member] | Maximum [Member]    
Accumulated Other Comprehensive Income (Loss) [Line Items]    
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Date Apr. 01, 2031  
Board Members And Consultants [Member] | Services Rendered [Member]    
Accumulated Other Comprehensive Income (Loss) [Line Items]    
Stock Issued During Period, Shares, Issued for Services 295,000 720,000
Share-Based Payment Arrangement, Noncash Expense $ 77,100 $ 129,600